TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
26 hedge funds and large institutions have $53.1M invested in Trillium Therapeutics Inc. in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
Holders
26
Holding in Top 10
–
Calls
$256K
Puts
$171K
Top Buyers
| 1 | +$15.8M | |
| 2 | +$1.45M | |
| 3 | +$1.14M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.09M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$792K |
Top Sellers
| 1 | -$2.21M | |
| 2 | -$1.21M | |
| 3 | -$807K | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$365K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$116K |